An Examine on Effect of Mergers and Acquisitions on the Viable overall Accomplishment of Indian Pharmaceutical Sector

Authors

  • K. A. Keerthi Prabu

Abstract

The study seeks to assess the effect of M&A over operational accomplishment over the Indian pharmaceutical zone during before and after amalgamation period. According to the review provided by Equity Master the Indian prescribed drugs market is the third highest by volume and thirteenth by value. The foreign trade of this sector to the United States will expand, as branded tablets well worth US$55 billion will become off-change all through 2017-2019 and self-generated finance and venture capital investments in this industry have increased at a rate of 38 percent year after year during first six months of the year 2017 due to prominent business of the zone.

Present study covers duration 1994-2016 to analyze the facts, every form of quantitative tools that have been taken up for analyze. The analysis is completely set up on processes data compiled through Ministry of Statistics and Programme Implementation (MOSPI) and Center for Monetary Indian Economy (CMIE) data base. The detailed literature provided proposes that the after-merger duration depicts a basic positive upliftment to utter no or negative effect. But this research found that improved in many firms specifically, in pure efficiency change during after merger period in the form of viable accomplishment of acquiring firms. Further, research has proved efficiency, M&A activities to reduce cost by achieving scale economies.

Downloads

Published

2020-01-07

Issue

Section

Articles